Podcast

Making Headway in GI Malignancies in Miami

Author(s):

We recently traveled to Miami, Florida for a State of the Science Summit™ on Gastrointestinal Malignancies, which featured insights from Florida Society of Clinical Oncology faculty.

We recently traveled to Miami, Florida for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from the Florida Society of Clinical Oncology discussed the novel agents that are generating excitement in advanced hepatocellular carcinoma and cholangiocarcinoma and the novel therapies and strategies that are propelling progress in gastric cancer.

Moreover, panelists shed light on the use of molecular testing in colorectal cancer and the current and investigational treatment strategies in the relapsed/refractory setting. Other key topics included remaining challenges with staging in pancreatic cancer, unanswered questions in the localized setting, and the benefits of olaparib in the metastatic setting.

Interested in attending an upcoming OncLive® State of the Science Summit in your area? Register today.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology, medical director, clinical professor, Supportive & Integrative Medicine, Department of Supportive Care Medicine, City of Hope
Rachna T. Shroff, MD, MS
Daneng Li, MD, associate professor, Department of Medical Oncology & Therapeutics Research, and co-director, Neuroendocrine Tumor Program, City of Hope
Dr Janjigian on 5-Year Data With Nivolumab Plus Chemotherapy in Gastric/GEJ/Esophageal Cancer
Susumu Hijioka, MD, PhD
Kanwal PS Raghav, MBBS, MD
Vikas S. Ostwal, MD
Dr Shreenivas on the Association Between MUC1 and CLDN18 in GI Cancers
Dr Strosberg on Cabozantinib vs Placebo in Patients With Advanced GI NETs
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center